Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Iron deficiency have been found to be linked to sleep disorders. Both genetic and environmental factors are risk factors for skewed iron metabolism, thus sleep disruptions in autism spectrum disorders (ASD). The aim of our study was to assess the prevalence of single nucleotide polymorphisms (SNPs) within transferrin gene (
TF)
rs1049296 C>T, rs3811647 G>A, transferrin receptor gene (
TFR)
rs7385804 A>C, and
hepcidin antimicrobial peptide
gene (
HAMP
)
rs10421768 A>G in Polish individuals with ASD and their impact on sleep pattern. There were 61 Caucasian participants with ASD and 57 non-ASD controls enrolled. Genotypes were determined by real-time PCR using TaqMan SNP assays. The Athens
Insomnia
Scale (AIS) was used to identify sleep disruptions. There were 32 cases (57.14%) with
insomnia
identified. In the ASD group, the defined counts of genotypes were as follows:
TF
rs1049296, C/C
n =
41 and C/T
n =
20;
TF
rs3811647, G/G
n =
22, G/A
n =
34, and A/A
n =
5;
TFR
rs7385804, A/A
n =
22, A/C
n =
29, and C/C
n =
10; and
HAMP
rs10421768, A/A
n =
34, A/G
n =
23, and G/G
n =
4. There were no homozygous carriers of the
TF
rs1049296 C>T minor allele in the ASD group. All analyzed SNPs were not found to be linked to
insomnia
. The investigated polymorphisms are not predictors of sleep disorders in the analyzed cohort of individuals with ASD.
...
PMID:The Prevalence of Insomnia and the Link between Iron Metabolism Genes Polymorphisms,
TF
rs1049296 C>T,
TF
rs3811647 G>A,
TFR
rs7385804 A>C,
HAMP
rs10421768 A>G and Sleep Disorders in Polish Individuals with ASD. 3193 2